Imatinib might constitute a treatment option for lung involvement in COVID-19
David Bello, Beatriz Jaenes‐Barrios, Alejandro Morales‐Ortega, José Manuel Ruiz‐Giardín, Virginia García, Begoña Frutos‐Pérez, Ana Isabel Farfán‐Sedano, C. de Ancos-Aracil, Fernando Bermejo, Mario García‐Gil, Antonio Zapatero, Juan San Martín
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Imatinib2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineLungVirologyInternal medicineIntensive care medicineInfectious disease (medical specialty)Myeloid leukemiaDiseaseOutbreakChronic Myeloid Leukemia TreatmentsPhagocytosis and Immune RegulationQuinazolinone synthesis and applications